Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients-Reference-Cited by-同舟云学术

Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients

Published:2010-04-20 Issue:9 Volume:16 Page:2646-2655
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Besser Michal J.,Shapira-Frommer Ronnie,Treves Avraham J.,Zippel Dov,Itzhaki Orit,Hershkovitz Liat,Levy Daphna,Kubi Adva,Hovav Einat,Chermoshniuk Natalia,Shalmon Bruria,Hardan Izhar,Catane Raphael,Markel Gal,Apter Sara,Ben-Nun Alon,Kuchuk Iryna,Shimoni Avichai,Nagler Arnon,Schachter Jacob

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 378 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Technological search of patents for the identification of devices with potential use in Tumor-infiltrating lymphocytes (TILs) research;World Patent Information;2024-03

2. Exercise sensitizes PD-1/PD-L1 immunotherapy as a hypoxia modulator in the tumor microenvironment of melanoma;Frontiers in Immunology;2023-10-09

3. “One more chance to survive”: the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy—a qualitative study and recommendations for future care;Journal of Cancer Survivorship;2023-08-22

4. IL-7R licenses a population of epigenetically poised memory CD8 ⁺ T cells with superior antitumor efficacy that are critical for melanoma memory;Proceedings of the National Academy of Sciences;2023-07-17

5. Advances in adoptive T-cell therapy for metastatic melanoma;Current Research in Translational Medicine;2023-07